Specification of drug substances and products : development and validation of analytical methods /
I tiakina i:
Ētahi atu kaituhi: | Riley, Christopher M., Rosanske, Thomas W., Riley, Shelley R. Rabel |
---|---|
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Amsterdam :
Elsevier,
[2014]
|
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Analytical method validation and instrument performance verification
I whakaputaina: (2004)
I whakaputaina: (2004)
Pharmaceutical drug analysis methodology - theory - instrumentation - pharmaceutical assays - cognote assays.
mā: Kar, Ashutosh
I whakaputaina: (2005)
mā: Kar, Ashutosh
I whakaputaina: (2005)
Practical approaches to method validation and essential instrument performance verification
I whakaputaina: (2010)
I whakaputaina: (2010)
Drug monitoring by HPLC recent developments /
mā: Samanidou, Victoria
I whakaputaina: (2010)
mā: Samanidou, Victoria
I whakaputaina: (2010)
Reviews in pharmaceutical and biomedical analysis
I whakaputaina: (2010)
I whakaputaina: (2010)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
I whakaputaina: (2008)
I whakaputaina: (2008)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
I whakaputaina: (2007)
I whakaputaina: (2007)
Flow injection analysis of pharmaceuticals automation in the laboratory /
mā: Martínez Calatayud, José
I whakaputaina: (1996)
mā: Martínez Calatayud, José
I whakaputaina: (1996)
Biomedical chromatography
I whakaputaina: (2010)
I whakaputaina: (2010)
HPLC methods for recently approved pharmaceuticals
mā: Lunn, George
I whakaputaina: (2005)
mā: Lunn, George
I whakaputaina: (2005)
Characterization of impurities and degradants using mass spectrometry
I whakaputaina: (2011)
I whakaputaina: (2011)
Dielectric analysis of pharmaceutical systems
mā: Craig, Duncan Q. M.
I whakaputaina: (1995)
mā: Craig, Duncan Q. M.
I whakaputaina: (1995)
Handbook of LC-MS bioanalysis best practices, experimental protocols, and regulations /
I whakaputaina: (2013)
I whakaputaina: (2013)
The selection and use of essential medicines
I whakaputaina: (2006)
I whakaputaina: (2006)
WHO Expert Committee on Biological Standardization fifty-sixth report.
I whakaputaina: (2007)
I whakaputaina: (2007)
WHO Expert Committee on Biological Standardization : sixtieth report /
I whakaputaina: (2013)
I whakaputaina: (2013)
Who Expert Committee on Biological Standardization : sixty-second report.
I whakaputaina: (2013)
I whakaputaina: (2013)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
mā: Osmane, Malik
I whakaputaina: (2014)
mā: Osmane, Malik
I whakaputaina: (2014)
Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
mā: Willig, Sidney H., 1919-
I whakaputaina: (2000)
mā: Willig, Sidney H., 1919-
I whakaputaina: (2000)
The war against counterfeit medicine my story /
mā: Akunyili, Dora Nkem
I whakaputaina: (2011)
mā: Akunyili, Dora Nkem
I whakaputaina: (2011)
Critical pathways to success in CNS drug development
I whakaputaina: (2010)
I whakaputaina: (2010)
WHO Expert Committee on Biological Standardization : sixty-third report. /
I whakaputaina: (2014)
I whakaputaina: (2014)
Continuous processing in pharmaceutical manufacturing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Biological drug products : development and strategies /
I whakaputaina: (2013)
I whakaputaina: (2013)
Mass spectrometry in sports drug testing characterization of prohibited substances and doping control analytical assays /
mā: Thevis, Mario, 1973-
I whakaputaina: (2010)
mā: Thevis, Mario, 1973-
I whakaputaina: (2010)
Target validation in drug discovery
I whakaputaina: (2006)
I whakaputaina: (2006)
Advanced drug design and development a medicinal chemistry approach /
I whakaputaina: (1994)
I whakaputaina: (1994)
Formulation and analytical development for low-dose oral drug products
I whakaputaina: (2009)
I whakaputaina: (2009)
Drug design cutting edge approaches /
I whakaputaina: (2002)
I whakaputaina: (2002)
Substance misuse the implications of research, policy and practice /
I whakaputaina: (2010)
I whakaputaina: (2010)
Illicit drugs in the environment occurrence, analysis, and fate using mass spectrometry /
I whakaputaina: (2011)
I whakaputaina: (2011)
Stereoselective synthesis of drugs and natural products
I whakaputaina: (2013)
I whakaputaina: (2013)
Drug-drug interactions in pharmaceutical development
I whakaputaina: (2008)
I whakaputaina: (2008)
Drug and substance abuse in tertiary institutions in Kenya : a situational analysis /
I whakaputaina: (2010)
I whakaputaina: (2010)
On drugs
mā: Lenson, David, 1945-
I whakaputaina: (1995)
mā: Lenson, David, 1945-
I whakaputaina: (1995)
Substance withdrawal syndrome
I whakaputaina: (2009)
I whakaputaina: (2009)
Drug smugglers on drug smuggling lessons from the inside /
mā: Decker, Scott H.
I whakaputaina: (2008)
mā: Decker, Scott H.
I whakaputaina: (2008)
Substance abuse a global view /
I whakaputaina: (2002)
I whakaputaina: (2002)
The handbook of drugs and society /
I whakaputaina: (2016)
I whakaputaina: (2016)
Mass spectrometry in drug metabolism and disposition basic principles and applications /
I whakaputaina: (2011)
I whakaputaina: (2011)
Ngā tūemi rite
-
Analytical method validation and instrument performance verification
I whakaputaina: (2004) -
Pharmaceutical drug analysis methodology - theory - instrumentation - pharmaceutical assays - cognote assays.
mā: Kar, Ashutosh
I whakaputaina: (2005) -
Practical approaches to method validation and essential instrument performance verification
I whakaputaina: (2010) -
Drug monitoring by HPLC recent developments /
mā: Samanidou, Victoria
I whakaputaina: (2010) -
Reviews in pharmaceutical and biomedical analysis
I whakaputaina: (2010)